Standard
Retrospective analysis to compare the efficacy of oral (O) vs. intravenous (IV) etoposide given in combination with carboplatin for small cell lung cancer (SCLC), extensive disease (ED). / Meliemgaard, Anders; Hersby, Ditte Stampe; Chaudhary, Farruhk Naheed; Langer, Seppo W.
2017. Abstract fra 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, Israel.
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › fagfællebedømt
Harvard
Meliemgaard, A, Hersby, DS, Chaudhary, FN
& Langer, SW 2017, '
Retrospective analysis to compare the efficacy of oral (O) vs. intravenous (IV) etoposide given in combination with carboplatin for small cell lung cancer (SCLC), extensive disease (ED)', 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, Israel,
02/06/2017 -
07/06/2017.
https://doi.org/10.1200/JCO.2017.35.15_suppl.e20020APA
Meliemgaard, A., Hersby, D. S., Chaudhary, F. N.
, & Langer, S. W. (2017).
Retrospective analysis to compare the efficacy of oral (O) vs. intravenous (IV) etoposide given in combination with carboplatin for small cell lung cancer (SCLC), extensive disease (ED). Abstract fra 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, Israel.
https://doi.org/10.1200/JCO.2017.35.15_suppl.e20020Vancouver
Meliemgaard A, Hersby DS, Chaudhary FN
, Langer SW.
Retrospective analysis to compare the efficacy of oral (O) vs. intravenous (IV) etoposide given in combination with carboplatin for small cell lung cancer (SCLC), extensive disease (ED). 2017. Abstract fra 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, Israel.
https://doi.org/10.1200/JCO.2017.35.15_suppl.e20020Author
Meliemgaard, Anders ; Hersby, Ditte Stampe ; Chaudhary, Farruhk Naheed ; Langer, Seppo W. / Retrospective analysis to compare the efficacy of oral (O) vs. intravenous (IV) etoposide given in combination with carboplatin for small cell lung cancer (SCLC), extensive disease (ED). Abstract fra 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, Israel.6 s.
Bibtex
@conference{16ff6015189547e68f1124bc4482d0fb,
title = "Retrospective analysis to compare the efficacy of oral (O) vs. intravenous (IV) etoposide given in combination with carboplatin for small cell lung cancer (SCLC), extensive disease (ED)",
author = "Anders Meliemgaard and Hersby, {Ditte Stampe} and Chaudhary, {Farruhk Naheed} and Langer, {Seppo W.}",
year = "2017",
doi = "10.1200/JCO.2017.35.15_suppl.e20020",
language = "English",
note = "53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO) ; Conference date: 02-06-2017 Through 07-06-2017",
}
RIS
TY - ABST
T1 - Retrospective analysis to compare the efficacy of oral (O) vs. intravenous (IV) etoposide given in combination with carboplatin for small cell lung cancer (SCLC), extensive disease (ED)
AU - Meliemgaard, Anders
AU - Hersby, Ditte Stampe
AU - Chaudhary, Farruhk Naheed
AU - Langer, Seppo W.
PY - 2017
Y1 - 2017
U2 - 10.1200/JCO.2017.35.15_suppl.e20020
DO - 10.1200/JCO.2017.35.15_suppl.e20020
M3 - Conference abstract for conference
T2 - 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Y2 - 2 June 2017 through 7 June 2017
ER -
